Rare Disorders or disease
Statistics and Figures on Prevalence of Genetic and Rare Diseases
Although rare and genetic diseases, and many times the symptoms, are uncommon to most doctors, rare diseases as a whole represent a large medical challenge. Combine this with the lack of financial or market incentives to treat or cure rare diseases, and you have a serious public health problem.
Here are a few statistics and facts to illustrate the breadth of the rare disease problem worldwide.
- 30 million people in the United States are living with rare diseases. This equates to 1 in 10 Americans or 10% of the U.S. population
- Similar to the United States, Europe has approximately 30 million people living with rare diseases. It is estimated that 350 million people worldwide suffer from rare diseases
- If all of the people with rare diseases lived in one country, it would be the world’s 3rd most populous country
- In the United States, a condition is considered “rare” it affects fewer than 200, 000 persons combined in a particular rare disease group. International definitions on rare diseases vary. For example in the UK, a disease is considered rare if it affects fewer than 50, 000 citizens per disease
- 80% of rare diseases are genetic in origin, and thus are present throughout a person’s life, even if symptoms do not immediately appear
- Approximately 50% of the people affected by rare diseases are children
- 30% of children with rare disease will not live to see their 5th birthday
- Rare diseases are responsible for 35% of deaths in the first year of life
- The prevalence distribution of rare diseases is skewed – 80% of all rare disease patients are affected by approximately 350 rare diseases
You might also like
Rare brain disorder suspected in death.(Health)(Fatal illness: Doctors say Creutzfeldt-Jakob Disease may have killed Jerry Ray Collins.): An article from: The Register-Guard (Eugene, OR)
Book (The Register Guard)
Provinces and territories talk health care — Canada NewsWire
Participating provincial and territorial health ministers discussed the significant challenges they face in providing new drug therapies to treat rare diseases.